Explore All Access
Check if your research matches the topics covered in Pharmacoepidemiology and Drug Safety?
- Degree of match
- Common matching concepts
- Additional journal recommendations
Pharmacoepidemiology and Drug Safety : Impact Factor & More
eISSN: 1099-1557pISSN: 1053-8569
Share this on:
Check your submission readiness
Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.
Pharmacoepidemiology and Drug Safety Key Metrics
CiteScore 
4
Impact Factor
< 5
SJR
Q2Epidemiology
SNIP
1.03
Time to Accept
6
Mo
Time to Publish
View Chart Mo
Time to Publish
Sign up now and unlock a detailed chart of Time to publish for this journal
% of papers by time taken from submission to publication
0 to 3 months3%
4 to 6 months34%
7 to 9 months40%
Above 9 months23%
Did you find this useful?
Topics Covered on Pharmacoepidemiology and Drug Safety
Confidence interval
Cohort study
Pregnancy
Diuretic
Diverticular disease
Polypharmacy
Drug discovery
Community hospital
Atrial fibrillation
Rheumatoid arthritis
Type 2 diabetes
Machine learning
Claims data
Pharmacoepidemiology
Metoprolol
Odds ratio
Biosimilar
Antidepressant
Randomized controlled trial
Nonsteroidal
Pharmacoepidemiology and Drug Safety Journal Specifications
| Overview | |
| Publisher | WILEY |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 1992 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Pharmacoepidemiology and Drug Safety ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Pharmacoepidemiology and Drug Safety
Post-Marketing Safety of Ustekinumab Based on 14-Year Follow-Up in Danish National Patient Data.
- 1 Dec 2024
- Pharmacoepidemiology and drug safety
Determining Targets for Antiretroviral Drug Concentrations: A Causal Framework Illustrated With Pediatric Efavirenz Data From the CHAPAS-3 Trial.
- 1 Dec 2024
- Pharmacoepidemiology and drug safety
Oxymorphone and Oxycodone Pharmacy Purchases in US Counties: Prelude to the Largest Rural Human Immunodeficiency Virus Outbreak in US History.
- 1 Dec 2024
- Pharmacoepidemiology and drug safety
Commentary/Response to Damkier etal.
- 1 Dec 2024
- Pharmacoepidemiology and drug safety
Title not available
- 1 Dec 2024
- Pharmacoepidemiology and Drug Safety
Does Physicians' Clinical Competence, Communication Ability, or Cultural Background Influence Potentially Inappropriate Prescribing of Benzodiazepines and Z-Drugs Among Older Adults With Insomnia?
- 1 Dec 2024
- Pharmacoepidemiology and drug safety
Post-Marketing Safety of Ustekinumab Based on 14-Year Follow-Up in Danish National Patient Data.
- 1 Dec 2024
- Pharmacoepidemiology and drug safety
Determining Targets for Antiretroviral Drug Concentrations: A Causal Framework Illustrated With Pediatric Efavirenz Data From the CHAPAS-3 Trial.
- 1 Dec 2024
- Pharmacoepidemiology and drug safety
Oxymorphone and Oxycodone Pharmacy Purchases in US Counties: Prelude to the Largest Rural Human Immunodeficiency Virus Outbreak in US History.
- 1 Dec 2024
- Pharmacoepidemiology and drug safety
Commentary/Response to Damkier etal.
- 1 Dec 2024
- Pharmacoepidemiology and drug safety
Title not available
- 1 Dec 2024
- Pharmacoepidemiology and Drug Safety
Does Physicians' Clinical Competence, Communication Ability, or Cultural Background Influence Potentially Inappropriate Prescribing of Benzodiazepines and Z-Drugs Among Older Adults With Insomnia?
- 1 Dec 2024
- Pharmacoepidemiology and drug safety
Compare Similar Journals with Pharmacoepidemiology and Drug Safety
Select Journals to Compare with Pharmacoepidemiology and Drug Safety
Total journals - 9
You can select up to 3 Journals at a time
PLoS ONE
Publisher: PUBLIC LIBRARY SCIENCE
BMJ Open
Publisher: BMJ PUBLISHING GROUP
Scientific Reports
Publisher: NATURE PORTFOLIO
International Journal of Environmental Research and Public Health
Publisher: Multidisciplinary Digital Publishing Institute (MDPI)
Journal of Clinical Medicine
Publisher: MDPI
Medicine
Publisher: Elsevier
Journal of Clinical Oncology
Publisher: LIPPINCOTT WILLIAMS & WILKINS
European Heart Journal
Publisher: OXFORD UNIV PRESS
JAMA network open
Publisher: AMER MEDICAL ASSOC
0 Journals Selected to compare with
Pharmacoepidemiology and Drug Safety
Compare journals across 7 parameters SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
Get detailed Journal comparison report on your email by signing up
FAQs on Pharmacoepidemiology and Drug Safety
How long has Pharmacoepidemiology and Drug Safety been actively publishing? 
Pharmacoepidemiology and Drug Safety has been in operation since 1992 till date.
What is the publishing frequency of Pharmacoepidemiology and Drug Safety?
Pharmacoepidemiology and Drug Safety published with a Monthly frequency.
How many articles did Pharmacoepidemiology and Drug Safety publish last year?
In 2023, Pharmacoepidemiology and Drug Safety publsihed 193 articles.
What is the eISSN & pISSN for Pharmacoepidemiology and Drug Safety?
For Pharmacoepidemiology and Drug Safety, eISSN is 1099-1557 and pISSN is 1053-8569.
What is Citescore for Pharmacoepidemiology and Drug Safety?
Citescore for Pharmacoepidemiology and Drug Safety is 4.
What is SNIP score for Pharmacoepidemiology and Drug Safety?
SNIP score for Pharmacoepidemiology and Drug Safety is 1.03.
What is the SJR for Pharmacoepidemiology and Drug Safety?
SJR for Pharmacoepidemiology and Drug Safety is Q2.
Who is the publisher of Pharmacoepidemiology and Drug Safety?
WILEY is the publisher of Pharmacoepidemiology and Drug Safety.
